Search Results

Safety and efficacy of olopatadine hydrochloride nasal spray 0.6% in pediatric subjects with allergic rhinitis

Authors: Berger, William E.; Ratner, Paul H.; Casale, Thomas B.; Meltzer, Eli O.; Wall, G. Michael

Source: Allergy and Asthma Proceedings, Volume 30, Number 6, November/December 2009 , pp. 612-623(12)

Publisher: OceanSide Publications, Inc

Efficacy of sublingual specific immunotherapy in intermittent and persistent allergic rhinitis in children: an observational case-control study on 171 patients. The EFESO-children Multicenter Trial

Authors: Acquistapace, Franca; Agostinis, Fabio; Castella, Vincenzo; Kantar, Ahmad; Novembre, Elio; Perrone, Maria Rosaria; Pietrasanta, Michele; Sambugaro, Renato; Milani, Massimo

Source: Pediatric Allergy and Immunology, Volume 20, Number 7, November 2009 , pp. 660-664(5)

Publisher: Blackwell Publishing

Seasonal changes in suppressive capacity of CD4⁺ CD25⁺ T cells from patients with hayfever are allergen-specific and may result in part from expansion of effector T cells among the CD25⁺ population

Authors: Anderson, A. E.; Mackerness, K. J.; Aizen, M.; Carr, V. A.; Nguyen, D.; Pre, F. Du; Durham, S. R.; Robinson, D. S.

Source: Clinical & Experimental Allergy, Volume 39, Number 11, November 2009 , pp. 1693-1699(7)

Publisher: Blackwell Publishing

Efficacy and safety of ciclesonide hydrofluoroalkane nasal aerosol once daily for the treatment of seasonal allergic rhinitis

Authors: LaForce, Craig; van Bavel, Julius; Meltzer, Eli O.; Wingertzahn, Mark A.

Source: Annals of Allergy, Asthma and Immunology, Volume 103, Number 2, August 2009 , pp. 166-173(8)

Publisher: American College of Allergy, Asthma, & Immunology

Evaluation of desloratadine on conjunctival allergen challenge-induced ocular symptoms

Authors: Torkildsen, G. L.; Gomes, P.; Welch, D.; Gopalan, G.; Srinivasan, S.

Source: Clinical & Experimental Allergy, Volume 39, Number 7, July 2009 , pp. 1052-1059(8)

Publisher: Blackwell Publishing

Combination of omalizumab and specific immunotherapy is superior to immunotherapy in patients with seasonal allergic rhinoconjunctivitis and co-morbid seasonal allergic asthma

Authors: Kopp, M. V.; Hamelmann, E.; Zielen, S.; Kamin, W.; Bergmann, K.-C.; Sieder, C.; Stenglein, S.; Seyfried, S.; Wahn, U.

Source: Clinical & Experimental Allergy, Volume 39, Number 2, February 2009 , pp. 271-279(9)

Publisher: Blackwell Publishing

Implementation of pre-seasonal sublingual immunotherapy with a five-grass pollen tablet during optimal dosage assessment

Authors: Horak, F.; Jaeger, S.; Worm, M.; Melac, M.; Didier, A.

Source: Clinical & Experimental Allergy, Volume 39, Number 3, March 2009 , pp. 394-400(7)

Publisher: Blackwell Publishing

Comparison of the efficacy and safety of bilastine 20 mg vs desloratadine 5 mg in seasonal allergic rhinitis patients

Authors: Bachert, C.; Kuna, P.; Sanquer, F.; Ivan, P.; Dimitrov, V.; Gorina, M. M.; van de Heyning, P.; Loureiro, A.

Source: Allergy, Volume 64, Number 1, January 2009 , pp. 158-165(8)

Publisher: Blackwell Publishing

Grass pollen allergy vaccine performance persists

Source: Inpharma, Volume 1, Number 1662, 2008-11-01 , pp. 6-6(1)

Publisher: Adis International

A sublingual grass pollen allergy vaccine tablet [Oralair Grasses] has shown positive results in an allergen challenge chamber study.

Source: Inpharma, Volume 1, Number 1654, 2008-09-06 , pp. 6-6(1)

Publisher: Adis International

Observational study of sublingual specific immunotherapy in persistent and intermittent allergic rhinitis: the EFESO trial

Authors: Milani, Massimo; Pecora, Silvia; Burastero, Samuele; EFESO Investigators Study Group,

Source: Current Medical Research and Opinion, Volume 24, Number 9, September 2008 , pp. 2719-2724(6)

Publisher: Informa Healthcare

Stallergenes has been granted marketing authorisation for its sublingual grass pollen allergy vaccine tablet

Source: Inpharma, Volume 1, Number 1644, 2008-06-28 , pp. 18-18(1)

Publisher: Adis International

A follow-up study of immunotherapy-treated birch-allergic patients: effect on the expression of chemokines in the nasal mucosa

Authors: Plewako, H.; Holmberg, K.; Oancea, I.; Gotlib, T.; Samoliński, B.; Rak, S.

Source: Clinical & Experimental Allergy, Volume 38, Number 7, July 2008 , pp. 1124-1131(8)

Publisher: Blackwell Publishing

Immunotherapy in children and adolescents with allergic rhinoconjunctivitis: a systematic review

Authors: Röder, Esther; Berger, Marjolein Y.; de Groot, Hans; van Wijk, Roy Gerth

Source: Pediatric Allergy and Immunology, Volume 19, Number 3, May 2008 , pp. 197-207(11)

Publisher: Blackwell Publishing

Ocular symptom reduction in patients with seasonal allergic rhinitis treated with the intranasal corticosteroid mometasone furoate

Author: Bielory, Leonard

Source: Annals of Allergy, Asthma and Immunology, Volume 100, Number 3, March 2008 , pp. 272-279(8)

Publisher: American College of Allergy, Asthma, & Immunology

Comprehensive report of the efficacy, safety, quality of life, and work impact of Olopatadine 0.6% and Olopatadine 0.4% treatment in patients with seasonal allergic rhinitis

Authors: Fairchild, Carol J.; Meltzer, Eli O.; Roland, Peter S.; Wells, David; Drake, Margaret; Wall, G. Michael

Source: Allergy and Asthma Proceedings, Volume 28, Number 6, November-December 2007 , pp. 716-723(8)

Publisher: OceanSide Publications, Inc

Sublingual-swallow immunotherapy with standardized 3-grass pollen extract: a double-blind, placebo-controlled study

Authors: de Blay, Frédéric; Barnig, Cindy; Kanny, Gisèle; Purohit, Ashok; Leynadier, Francisque; de Lara, J M.T.; Chabane, Habib; Guérin, Laurence

Source: Annals of Allergy, Asthma and Immunology, Volume 99, Number 5, November 2007 , pp. 453-461(9)

Publisher: American College of Allergy, Asthma, & Immunology

Quantification of atopy and the probability of rhinitis in preschool children: a population-based birth cohort study

Authors: Marinho, S.; Simpson, A.; Söderström, L.; Woodcock, A.; Ahlstedt, S.; Custovic, A.

Source: Allergy, Volume 62, Number 12, December 2007 , pp. 1379-1386(8)

Publisher: Blackwell Publishing

Desloratadine improves quality of life and symptom severity in patients with allergic rhinitis

Authors: Pradalier, A.; Neukirch, C.; Dreyfus, I.; Devillier, P.

Source: Allergy, Volume 62, Number 11, November 2007 , pp. 1331-1334(4)

Publisher: Blackwell Publishing

Effect of grass pollen immunotherapy with Alutard SQ^® on quality of life in seasonal allergic rhinoconjunctivitis

Authors: Powell, R. J.; Frew, A. J.; Corrigan, C. J.; Durham, S. R.

Source: Allergy, Volume 62, Number 11, November 2007 , pp. 1335-1338(4)

Publisher: Blackwell Publishing